DrugPatentWatch Database Preview
Ipca Labs Ltd Company Profile
What is the competitive landscape for IPCA LABS LTD, and what generic and branded alternatives to IPCA LABS LTD drugs are available?
IPCA LABS LTD has eighteen approved drugs.
Summary for Ipca Labs Ltd
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 16 |
| NDAs: | 18 |
Drugs and US Patents for Ipca Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ipca Labs Ltd | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 040766-001 | Jun 14, 2007 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ipca Labs Ltd | ATENOLOL | atenolol | TABLET;ORAL | 077877-002 | Dec 27, 2006 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ipca Labs Ltd | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 200104-007 | Jun 27, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ipca Labs Ltd | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | TABLET;ORAL | 078807-001 | Jun 12, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
